Abstract: The present invention comprises buffered ophthalmic formulations and methods for antiseptically treating or pretreating ocular surfaces for invasive surgical or treatment procedures. The buffered compositions of the present invention comprise antiseptic agents within an aqueous gel or semi-gel formulation, to provide enhanced methods of treating ocular surfaces prior to surgical or other invasive procedures. Buffered ophthalmic formulations provide additional benefits to standard non-buffered preparations including decreased toxicity to the ocular surfaces, which improves post-procedural discomfort and vision.
Type:
Application
Filed:
June 5, 2023
Publication date:
December 5, 2024
Applicant:
PANASEEA, LLC
Inventors:
Byron S. LADD, Christopher K. CURRIN, Stephen DRUMMOND
Abstract: The present invention comprises buffered compositions and methods for antiseptically treating or pretreating anatomic surfaces for invasive surgical or treatment procedures. The compositions and methods according to the present invention find use in treating skin, gums and ocular surfaces for injections and other procedures. The buffered compositions of the present invention comprise antiseptic agents, optionally within an aqueous gel or semi-gel formulation, to provide enhanced methods of treating anatomic surfaces such as the gums or eye prior to surgical or other invasive procedures. Buffered compositions provide additional benefits to standard non-buffered preparations including decreased toxicity to the anatomic surfaces, which improves post-procedural discomfort and vision in the case of ocular surfaces.
Type:
Application
Filed:
January 11, 2018
Publication date:
July 11, 2019
Applicant:
Panaseea, LLC
Inventors:
Byron S. LADD, Christopher K. CURRIN, Stephen DRUMMOND